Skip to main content
Clinical Trials/ISRCTN57022672
ISRCTN57022672Completed未知

Effect of change in pancreas and liver fat content upon beta cell function and hepatic insulin action during weight loss in type 2 diabetes: a non-randomised interventional treatment trial

ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)0 sites22 target enrollmentStarted: April 23, 2010Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
22

Study Overview

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • For type 2 diabetes volunteers:
  • 1. Duration of diabetes up to 2 years
  • 2. Aged between 25 - 65 years, either sex
  • 3. Body mass index (BMI) of 30 - 40 kg/m^2 with stable body weight for preceeding 3 months
  • 4. HbA1c between 6.2 and 9.0%
  • 5. On treatment with diet alone or diet plus metformin
  • For healthy controls:
  • 1. Normal glucose tolerance plasma fasting triglyceride less than 1.8 mmol/l
  • 2. No family history of type 2 diabetes
  • 3. Matching BMI and age

Exclusion Criteria

  • 1. Kidney dysfunction (serum creatinine greater than 150 micromol/l)
  • 2. Liver dysfunction (serum alanine aminotransferase [ALT] greater than 2.5 upper limit normal)
  • 3. Contraindications to magnetic resonance imaging (MRI) (metal implants and claustrophobia)
  • 4. Consumption of greater than 14 units of alcohol per week
  • 5. Treatment with sulphonylureas, thiazolidinediones, steroids or beta-blockers

Investigators

Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)

Similar Trials

Effect of change in pancreas and liver fat... | Clinical Trial